Podcast
Speaking of Urology podcast: Dr. Angela Smith discusses Jelmyto for low-grade UTUC
Author(s):
In this episode, Angela B. Smith, MD, MS, of UNC Lineberger Comprehensive Cancer Center, discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.
Related Videos
Case 3: A 49-Year-Old Man With Recurrent Non–Muscle-Invasive Bladder Cancer
Case 2: A 68-Year-Old Woman With Non–Muscle-Invasive Bladder Cancer
Study findings highlight gender gaps in oncology authorship and citation
Case 1: A 79-Year-Old Man With Non–Muscle-Invasive Bladder Cancer
Non–Muscle Invasive-Bladder Cancer Overview
Laura Davis, MD, on link between microplastics and bladder cancer
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
Expert discusses the NMIBC trials landscape
John Gore, MD, on bladder preservation in muscle–invasive bladder cancer
Related Content
